ClinicalTrials.Veeva

Menu

VWCR to Improve Cardiovascular Health and Outcomes Among Cardiac Patients: A Multicenter Randomized Clinical Trial Protocol (Destination Cardiac Rehab Study)

Mayo Clinic logo

Mayo Clinic

Status

Not yet enrolling

Conditions

Heart Diseases

Treatments

Other: Virtual Cardiac Rehabilitation
Other: In-Person Cardiac Rehabilitation

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT07745894
1R01LM014760-01 (U.S. NIH Grant/Contract)
25-008267

Details and patient eligibility

About

The purpose of this research is to compare health outcomes and participation between a virtual world cardiac rehabilitation (Destination Cardiac Rehab) program and the standard of care Center-based Cardiac Rehabilitation program. Destination Cardiac Rehab, developed with input from patients with heart disease and their caregivers, is a 3-D, interactive program offering an affordable telehealth option for cardiac rehabilitation (cardiac rehab) that can be done from home or any place that you can access the Internet with a computer.

Enrollment

150 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Indication for CR according to Centers for Medicare & Medicaid Services (CMS) guidelines:

    • Myocardial infarction within the preceding 12 months
    • Coronary artery bypass surgery
    • Current stable angina (chest pain)
    • Heart valve repair or replacement
    • Percutaneous transluminal coronary angioplasty (PTCA) or coronary stenting
    • Heart or heart-lung transplant
    • Stable chronic heart failure
  • Aged ≥18 years

  • Basic Internet navigation skills

  • Active email address

Exclusion criteria

  • High risk patients according to the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) risk stratification103 given safety concern of unsupervised exercise:

    • Sudden cardiac arrest survivor
    • Receiving continuous inotropic support
    • Presence of a mechanical circulatory support device
    • Decompensated heart failure
    • Symptomatic valvular heart disease
    • Uncontrolled angina
    • Presence of hemodynamically unstable dysrhythmias (e.g., ventricular tachycardia)
  • Pregnant (due to associated hormonal and weight changes)

  • Non-English-speaking

  • Visual/hearing impairment or mental disability that would preclude independent use of the VW platform

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

150 participants in 2 patient groups

Virtual World-based Cardiac Rehabilitation
Experimental group
Treatment:
Other: Virtual Cardiac Rehabilitation
Control Arm
Active Comparator group
Treatment:
Other: In-Person Cardiac Rehabilitation

Trial contacts and locations

3

Loading...

Central trial contact

Lainey Moen; Ashton Krogman

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems